Tissue Microarrays (TMAs)
High-Throughput Validation: Precision-Engineered TMAs for Accelerated Biomarker Discovery
Creative Bioarray provides high-density Tissue Microarrays (TMAs) designed to maximize research efficiency. By assembling hundreds of miniaturized tissue cores onto a single slide, our TMAs enable simultaneous analysis of protein or gene expression across diverse biospecimens under identical experimental conditions, significantly reducing reagent consumption and technical variability.
Product Features
Extensive Cohort Selection
Our portfolio includes multiple cancer types, normal controls, and disease-specific arrays (e.g., neurodegenerative, inflammatory), covering human, NHP, and common laboratory animal models.
Standardized Core Precision
Each TMA is constructed with precise core diameters (typically 0.6mm - 2.0mm) and optimized spacing, ensuring structural integrity and consistent results across IHC, ISH, and FISH applications.
Application-Specific Designs
We offer specialized array formats, including multi-tumor arrays, progression arrays (from normal to metastatic), and custom-configured layouts tailored to your unique study objectives.
Why Choose Our Tissue Microarrays?
Unmatched Statistical Power
- Simultaneous analysis of large cohorts (up to 400+ cores per slide)
- Elimination of slide-to-slide batch effects
- Preservation of limited and precious donor tissues
- Cost-effective screening of experimental therapeutic targets
- High-resolution digital pathology compatible
Verified Clinical Integrity
- Expert pathologist-validated core selection (H&E guided)
- Comprehensive donor clinical data and pathology reports
- Stringent QC for morphology and biomarker antigenicity
- Ethically sourced specimens with full IRB/EC compliance
- Seamless integration with our IHC staining services
A major differentiator of our Tissue Microarray portfolio is the combination of high-density sampling and deep clinical characterization. We ensure that every core represents the specific pathology of interest, providing researchers with a robust platform for statistically significant biomarker validation.
Request a Quote or Custom Solution
Whether you need a validated tumor progression array or a custom-designed TMA featuring specific donor profiles, Creative Bioarray is committed to delivering high-performance solutions backed by technical expertise and ethical sourcing.
Please tell us your target disease indications, required core density, and clinical criteria, and our specialists will help you identify or design the optimal array for your research.
Filters Clear all filters
Species
- Human (742)
- Monkey (7)
- Mouse (16)
- Rat (13)
Source
- Adipose (1)
- Adrenal Gland (2)
- Appendix (2)
- Bladder (6)
- Blood Vessel (1)
- Bone (8)
- Bone Marrow (3)
- Brain (13)
- Breast (16)
- Cartilage (4)
- Cervix (9)
- Colon (116)
- Endometrium (4)
- Esophagus (73)
- Gallbladder (2)
- Heart (7)
- Intestine (160)
- Kidney (24)
- Large Intestine (2)
- Liver (112)
- Lung (48)
- Multiple Organs (82)
- Muscle (3)
- Ovary (8)
- Pancreas (43)
- Penis (5)
- Prostate (11)
- Rectum (42)
- Skin (33)
- Small Intestine (7)
- Smooth Muscle (2)
- Spleen (8)
- Stomach (83)
- Testis (9)
- Thyroid Gland (5)
- Ureter (1)
- Urethra (1)
- Uterus (13)
Disease
- Cancer (696)
- Crohn's Disease (3)
- Gastric Ulcer (4)
- Gastritis (5)
- Hepatitis (8)
- Liver Cirrhosis (17)
- Normal (443)
- Pancreatitis (4)
- Ulcerative Colitis (2)
Description: Human esophagus squamous cell carcinoma (Grade I, II and III), 45 cases, duplicate cores per cancer.
Description: Human esophagus squamous cell carcinoma (Grade II), 45 cases, duplicate cores per cancer.
Description: Human esophagus squamous cell carcinoma (Grade II), 45 cases, duplicate cores per cancer.
Description: Human esophagus squamous cell carcinoma (Grade II-III and III), 45 cases, duplicate cores per ...
Description: Human esophagus squamous cell carcinoma (Grade II), 45 cases, duplicate cores per cancer.
Description: Human esophagus squamous cell carcinoma, 50 cases.
Description: Esophageal squamous cell carcinoma tissue array, 60 cases/ 60 cores. Patient survival data is ...
Description: Esophageal squamous cancer tissue array, 93 cases, incliding survival data..
Description: Esophagus cancer test tissue microarray with normal tissue as control, including TNM, clinical ...
Description: Esophagus cancer tissue microarray for antibody screening, including TNM, clinical stage and ...
Description: Esophageal cancer tissue microarray for antibody screening, including TNM, clinical stage and ...
Description: Esophageal tumor tissue microarray, with stage, grade and matched adjacent tissue, 60 cases/120 ...
Description: Esophageal cancer tissue microarray, including TNM, clinical stage and pathology grade, 75 ...
Description: Middle-advanced stage esophagus cancer tissue microarray, including TNM, clinical stage and ...
Description: Esophagus squamous cell carcinoma and metastatic carcinoma tissue microarray, with adjacent tissue ...
Description: High density esophageal cancer tissue microarray, with normal tissue, grade and TNM, 69 cases/208 ...
Description: Esophageal cancer tissue microarray, 27 cases of esophageal squamous cell carcinoma, 3 ...
Description: High-density esophageal cancer and normal tissue microarray, with TNM and grade info, 208 cases/208 ...